214 related articles for article (PubMed ID: 32521458)
1. Drug delivery based pharmacological enhancement and current insights of quercetin with therapeutic potential against oral diseases.
Wang Y; Tao B; Wan Y; Sun Y; Wang L; Sun J; Li C
Biomed Pharmacother; 2020 Aug; 128():110372. PubMed ID: 32521458
[TBL] [Abstract][Full Text] [Related]
2. Procyanidins and Their Therapeutic Potential against Oral Diseases.
Chen H; Wang W; Yu S; Wang H; Tian Z; Zhu S
Molecules; 2022 May; 27(9):. PubMed ID: 35566283
[TBL] [Abstract][Full Text] [Related]
3. Quercetin-containing self-nanoemulsifying drug delivery system for improving oral bioavailability.
Tran TH; Guo Y; Song D; Bruno RS; Lu X
J Pharm Sci; 2014 Mar; 103(3):840-52. PubMed ID: 24464737
[TBL] [Abstract][Full Text] [Related]
4. Bioavailability of quercetin: problems and promises.
Cai X; Fang Z; Dou J; Yu A; Zhai G
Curr Med Chem; 2013; 20(20):2572-82. PubMed ID: 23514412
[TBL] [Abstract][Full Text] [Related]
5. Novel flavonoid-based biodegradable nanoparticles for effective oral delivery of etoposide by P-glycoprotein modulation: an in vitro, ex vivo and in vivo investigations.
Fatma S; Talegaonkar S; Iqbal Z; Panda AK; Negi LM; Goswami DG; Tariq M
Drug Deliv; 2016; 23(2):500-11. PubMed ID: 24937381
[TBL] [Abstract][Full Text] [Related]
6. Enhanced bioactivity and efficient delivery of quercetin through nanoliposomal encapsulation using rice bran phospholipids.
Rodriguez EB; Almeda RA; Vidallon MLP; Reyes CT
J Sci Food Agric; 2019 Mar; 99(4):1980-1989. PubMed ID: 30270448
[TBL] [Abstract][Full Text] [Related]
7. Quercetin Loaded Nanoparticles in Targeting Cancer: Recent Development.
Vinayak M; Maurya AK
Anticancer Agents Med Chem; 2019; 19(13):1560-1576. PubMed ID: 31284873
[TBL] [Abstract][Full Text] [Related]
8. Development of quercetin-phospholipid complex to improve the bioavailability and protection effects against carbon tetrachloride-induced hepatotoxicity in SD rats.
Zhang K; Zhang M; Liu Z; Zhang Y; Gu L; Hu G; Chen X; Jia J
Fitoterapia; 2016 Sep; 113():102-9. PubMed ID: 27431774
[TBL] [Abstract][Full Text] [Related]
9. Nanoparticle-delivered quercetin for cancer therapy.
Men K; Duan X; Wei XW; Gou ML; Huang MJ; Chen LJ; Qian ZY; Wei YQ
Anticancer Agents Med Chem; 2014; 14(6):826-32. PubMed ID: 24851877
[TBL] [Abstract][Full Text] [Related]
10. Novel self-emulsifying formulation of quercetin for improved in vivo antioxidant potential: implications for drug-induced cardiotoxicity and nephrotoxicity.
Jain S; Jain AK; Pohekar M; Thanki K
Free Radic Biol Med; 2013 Dec; 65():117-130. PubMed ID: 23792276
[TBL] [Abstract][Full Text] [Related]
11. Enhancing the potential preclinical and clinical benefits of quercetin through novel drug delivery systems.
Khursheed R; Singh SK; Wadhwa S; Gulati M; Awasthi A
Drug Discov Today; 2020 Jan; 25(1):209-222. PubMed ID: 31707120
[TBL] [Abstract][Full Text] [Related]
12. Quercetin-phospholipid complex: an amorphous pharmaceutical system in herbal drug delivery.
Singh D; Rawat MS; Semalty A; Semalty M
Curr Drug Discov Technol; 2012 Mar; 9(1):17-24. PubMed ID: 21644920
[TBL] [Abstract][Full Text] [Related]
13. Effect of the oral administration of nanoencapsulated quercetin on a mouse model of Alzheimer's disease.
Moreno LCGEI; Puerta E; Suárez-Santiago JE; Santos-Magalhães NS; Ramirez MJ; Irache JM
Int J Pharm; 2017 Jan; 517(1-2):50-57. PubMed ID: 27915007
[TBL] [Abstract][Full Text] [Related]
14. Zein nanoparticles for oral delivery of quercetin: Pharmacokinetic studies and preventive anti-inflammatory effects in a mouse model of endotoxemia.
Penalva R; González-Navarro CJ; Gamazo C; Esparza I; Irache JM
Nanomedicine; 2017 Jan; 13(1):103-110. PubMed ID: 27615118
[TBL] [Abstract][Full Text] [Related]
15. Insulin- and quercetin-loaded liquid crystalline nanoparticles: implications on oral bioavailability, antidiabetic and antioxidant efficacy.
Singh S; Kushwah V; Agrawal AK; Jain S
Nanomedicine (Lond); 2018 Mar; 13(5):521-537. PubMed ID: 29383973
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a liposomal copper(II)-quercetin formulation suitable for parenteral use.
Chen KTJ; Anantha M; Leung AWY; Kulkarni JA; Militao GGC; Wehbe M; Sutherland B; Cullis PR; Bally MB
Drug Deliv Transl Res; 2020 Feb; 10(1):202-215. PubMed ID: 31482519
[TBL] [Abstract][Full Text] [Related]
17. Casein nanoparticles in combination with 2-hydroxypropyl-β-cyclodextrin improves the oral bioavailability of quercetin.
Peñalva R; Esparza I; Morales-Gracia J; González-Navarro CJ; Larrañeta E; Irache JM
Int J Pharm; 2019 Oct; 570():118652. PubMed ID: 31472219
[TBL] [Abstract][Full Text] [Related]
18. Nano Drug Delivery Strategies for an Oral Bioenhanced Quercetin Formulation.
Attar ES; Chaudhari VH; Deokar CG; Dyawanapelly S; Devarajan PV
Eur J Drug Metab Pharmacokinet; 2023 Sep; 48(5):495-514. PubMed ID: 37523008
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles.
Li H; Zhao X; Ma Y; Zhai G; Li L; Lou H
J Control Release; 2009 Feb; 133(3):238-44. PubMed ID: 18951932
[TBL] [Abstract][Full Text] [Related]
20. Preparation and in vitro and in vivo evaluation of quercetin-loaded mixed micelles for oral delivery.
Lu Z; Bu C; Hu W; Zhang H; Liu M; Lu M; Zhai G
Biosci Biotechnol Biochem; 2018 Feb; 82(2):238-246. PubMed ID: 29327653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
